In a secondary analysis of a 6-week placebo-controlled trial in 156 suicidal psychiatric inpatients, two intravenous ketamine infusions lowered self-rated psychological pain more than placebo from 40 min to 96 h, but not at weeks 2, 4 or 6.
Secondary analysisn = 156
Baryshnikov et al. Intravenous Ketamine reduces psychological pain in suicidal inpatients: A secondary analysis of a six-week randomized placebo-controlled trial